Reproductive Flashcards

1
Q

types of HRT for women

A
  • estrogen-only
  • progesterone-only
  • combined
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

If uterus is intact, you must balance ________ with ________.

A
  • estrogen
  • progesterone
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

first rule of HRT

A

smallest dose for shortest amount of time

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

estrogen replacement drugs

A
  • conjugated equine estrogens
  • estradiol
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Why do we balance estrogen with ______ when the uterus is intact?

A
  • estrogen
  • estrogen → uterine lining growth
    • overgrowth → risk of CA
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

expected action of estrogens

A
  • block bone resorption
  • reduce LDL
  • improve menopause Sx
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

estrogen routes

A
  • PO
  • TD
  • intravaginal
  • IM
  • IV
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

EPT

A

estrogen-progesterone therapy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

breast cancer increase with EPT

A

26%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

heart attack ↑ with EPT

A

29%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

stroke ↑ with EPT

A

41%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

VTE ↑ with EPT

A

double

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

EPT effect on colorectal cancer

A

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

hip Fx risk with EPT

A

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

AE of estrogen therapy

A
  • endometrial and ovarian cancers: prolonged postmenopausal estrogen therapy
  • risk for estrogen-dependent breast cancer
  • risk for embolic events (MI, CVA, DVT, PE)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

interventions for estrogen therapy

A
  • lowest effective dose for shortest time
  • monitor for breast CA, DVT
  • NO SMOKING
  • monitor lipids, HTN
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

contraindications for estrogen

A
  • strong Fm or personal Hx of CVD
  • undiagnosed abnormal vaginal bleeding
  • breast or other estrogen-based CA
  • Hx of DVT
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

estrogen interactions

A
  • ↓ effectiveness of warfarin
  • ↓ effect of estrogen: phenytoin
  • ↑ effect of estrogen: corticosteroids
  • smoking: ↑ risk of thrombophlebitis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

estrogen + warfarin =

A
  • ↓ effect of warfarin
  • monitor INR and PT
  • warfarin dose adjustment
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

estrogens + phenytoin =

A

monitor for ↓ estrogen effects

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

estrogens + corticosteroids =

A
  • ↑ effects of estrogen
  • monitor for ↑ effects
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

estrogens + smoking =

A
  • ↑ risk of thrombophelbitis
  • pt education
  • use alternative Tx if smoking persists
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

pt education for estrogens

A
  • take at same time daily
  • report abnormal bleeding
  • regular breast exams, GYN visits
  • DVT S/Sx
    • redness, warmth, tenderness, swelling in lower leg
  • D/C before surgery/prolonged immobilization
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

progesterone drugs

A
  • medroxyprogesterone
  • norethindrone
  • megestrol acetate
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
use
* required combo with estrogen in women with uterus * can be given alone for BC or HRT * control dysfunctional bleeding * Tx of * abnormal amenorrhea * endometriosis * advanced CAs * endometrial * breast * kidney * create cycle to treat infertility
26
routes for progesterone
* PO * IM * SQ * TD * intravaginal
27
HRT with the female hormone __________ has less risks than \_\_\_\_\_\_\_\_\_.
* progesterone * estrogen
28
AE of progesterone
* Br CA risk * thromboembolic events (MI, PE, thrombophlebitis, CVA) * breakthrough bleeding, amenorrhea, breast tenderness * edema * jaundice * migraines
29
interventions for breakthrough bleeding, amenorrhea, and breast tenderness on progesterone therapy
* baseline breast exam and Pap smear * report abnormal vaginal bleeding
30
progesterone admin/pt teaching
* monitor LFTs * baseline breast exam and Pap smear * monitor for DVT, CP, SOB * monitor BP, I&O, wt * notify provider of severe HA
31
progesterone interactions
* ↓ contraceptive effectiveness: carbamazepine, phenobarbital, phenytoin, and rifampin * ↑ risk of thrombophlebitis: smoking
32
progesterone + phenytoin =
* ↓ contraception * use backup method
33
progesterone + rifampin =
* ↓ contraception * use backup method
34
progesterone + carbamazepine =
* ↓ contraception * use backup method
35
progesterone + phenobarbital =
* ↓ contraception * use backup method
36
pt ed for progesterone
withdrawal bleeding for 3-7 days after D/C
37
BC vs HRT
* hormonal BC will have same effects as HRT * BC typically in higher doses than HRT * therapeutic intent and outcome are different
38
routes of BC
* PO * TD patch * vaginal ring * IM
39
combined oral contraceptives (COC)
* ethinyl estradiol/norethindrone * ethinyl estradiol/drospirenone * come in various dosages, some with varying dose per day (multiphasic)
40
monophasic COC
hormone amounts the same throughout the month/pack
41
multiphasic COC
* hormone amounts vary throughout pack/month to duplicate a cycle * come in biphasic, triphasic, quadraphasic
42
mini pill
* progesterone-only BC pill * norethindrone
43
The ____ \_\_\_\_ is not as reliable as COC.
mini pill
44
first rule of taking BC pills
take at the same time every day, especially mini pill
45
TD BC patch
* drug: ethinyl estradiol/norelgestromin * schedule: weekly, with 4th wk skipped for period * not good for obese pts * skin irritant
46
vaginal contraceptive ring
* estrogen-based * schedule: monthly; in for 3 wks, out for a week * have to be comfortable with inserting it
47
depot medroxyprogesterone acetate
* DMPA * route: IM * schedule: q 3 months * not good for long-term use * ideal for adolescents
48
Nuvaring
estrogen-based BC vaginal ring
49
Depo-Provera
IM progesterone-only BC
50
expected action of hormonal BC
* prevent ovulation * thicken cervical mucus * alter endometrial lining
51
AE of hormonal BC
* thromboembolic events (unlikely with progestin-only) * HTN * breakthrough or abnormal uterine bleeding * Br CA
52
breast CA risk with hormonal BC
* may ↑ growth of pre-existing breast CA * contraindicated for those with breast CA * breast exam before giving
53
interventions/pt teaching for breakthrough or abnormal bleeding
* pt: record duration and frequency of bleeding * evaluate for PG if 2 or more periods missed
54
nursing actions for hormonal BC
* r/o PG before starting BC * take pills at same time each day * missed pills * 1 missed: take 2 at next dose * 2 missed: take 2 for next 2 doses * 3 missed * use backup * stop pack * restart in 7 days * **progesterone-only, 1 missed: use backup**
55
IUD
intrauterine device
56
copper IUD
non-hormonal
57
hormonal IUDs
* Skyla * Mirena * small amt of progestin that acts only on uterine tissue
58
androgens
* testosterone * methyltestosterone
59
testosterone routes
* IM * TD * pellets (subdermal) * buccal tabs
60
testosterone action
* development of male sex traits * sperm production * ↑ muscle * ↑ synthesis of erythropoietin
61
uses for testosterone therapy
* hypogonadism in males * delayed male puberty * replacement for testicular failure * anemia (if not responsive to tradiational Tx) * postmenopausal breast CA * muscle wasting in male pts with AIDs * help with lethargy, libido, hair loss in females
62
testosterone's androgenic effects on women
* hirsutism * lowering of voice * acne * other undesired effects
63
testosterone's androgenic effects on men
* acne * priapism * ↑ hair growth
64
AE of testosterone
* androgenic (virilization) effects * premature epiphyseal closure * cholestatic hepatitis * hypercholesterolemia * ↑ growth of prostate CA * polycythemia * edema from salt and water retention * high abuse potential
65
premature epiphyseal closure
* epiphyseal plate: growth plate responsible for lengthening long bones * premature closure → ↓ mature height * monitor epiphysis with serial X-rays * do not give testosterone before puberty
66
pt ed for androgenic effects
notify provider
67
cholestatic hepatitis
* S/Sx * nausea * fatigue * pruritis * dark urine * jaundice * baseline/periodic LFTs
68
testosterone contraindications
* pre-pubescence * pregnancy * men with prostate or breast CA * hypercalcemia
69
labs for testosterone therapy
* LFTs * lipid panel * CBC (Hgb, Hct)
70
precautions for testosterone
* HF * HTN * cardiac, renal, or liver dz
71
testosterone admin
* wear gloves * wash hands after * use large muscle for IM injection * monitor women for masculinization
72
alpha1-adrenergic antagonists
* (-osin) * tamsulosin * alfuzosin * terazosin * doxazosin
73
alpha1-adrenergic antagonist action
↓ mechanical obstruction of urethra by relaxing smooth muscles of bladder and prostate
74
alpha1-adrenergic antagonist use
* urinary retention from * BPH * anesthesia * kidney stones
75
alpha1-adrenergic antagonist route
PO
76
BPH
benign prostatic hyperplasia
77
AE of alpha1-adrenergic antagonists
* hypotension * nasal congestion * dizziness * sleepiness * faintness * ejaculation failure, ↓ volume
78
nursing actions for alpha1-adrenergic antagonists
* monitor BP * pt teaching * rise slowly * don't drive or operate machinery at first or when changing dose
79
PDE5 inhibitor
phosphodiesterase type 5 inhibitor
80
PDE5 inhibitors
* -afil * sildenafil (Viagra) * tadalafil (Cialis) * vardenafil (Levitra)
81
PDE5 inhibitor action
* augments effect of nitric oxide release during sexual stim * enhances blood flow to corpus cavernosum to support erection
82
PDE5 inhibitor use
Tx of erectile dysfunction
83
AE of PDE5 inhibitors
* MI, sudden death: monitor risk factors, Hx of CV health * priapism
84
priapism
* prolonged erection of the penis * notify provider if erection lasts \> 4 hrs
85
contraindications for PDE5 inhibitors
nitrate use
86
precautions for PDE5 inhibitors
* CVD * prolonged QT wave
87
interactions with PDE5 inhibitors
* ↑ PDE5 plasma concentration * grapefruit * ketoconazole * erythromycin * cimetidine * ritonavir * fatal hypotension * nitrates * alpha blockers
88
PDE5 inhibitor route
PO